Prostate Cancer Treatment and Research

Prostate cancer becomes most dangerous when it spreads beyond the prostate and learns to survive despite therapies designed to block the androgen receptor, the protein that drives most tumor growth. Researchers are working to understand the molecular mechanisms behind this resistance, including how specific genetic mutations and gene fusions allow cancer cells to bypass hormone therapy and continue proliferating. Genomic profiling of tumors has opened new possibilities for matching patients to targeted treatments and immunotherapies, though identifying which patients will respond—and why—remains an active and unresolved challenge. Clinical trials are currently testing second-generation antiandrogens and combination strategies aimed at metastatic disease, with the broader goal of converting a fatal diagnosis into a manageable chronic condition.

Works

146,647

Total citations

1,473,940

Keywords

Prostate CancerAndrogen ReceptorGenomic ProfilingHormone TherapyMetastatic Prostate CancerImmunotherapy